Skip to Main content Skip to Footer content
What is Photodynamic Therapy?
Back to Articles
Articles National Cancer Institute September 25, 2026
Share This Article:

Photodynamic Therapy to Treat Cancer

Discover World-Class Cancer Care Close to Home

FCS has a national reputation for excellence that is reflected in exceptional and compassionate patient care, innovative clinical research, cutting-edge technologies, and advanced treatments. With nearly 100 locations, FCS serves patients throughout Florida. we are committed to providing world-class cancer care in community-based settings close to home.

Hereditary Cancer Spotlight: Ovarian Cancer — approximately 10-20% of ovarian cancer cases diagnosed are hereditary, caused by a pathogenic inherited mutation
Hereditary Cancer Spotlight: Ovarian Cancer

Approximately 10-20% of ovarian cancers are linked to inherited gene mutations. FCS explains germline testing, risk syndromes and who should be tested.

New FDA-approved drug offers hope for advanced pancreatic cancer patients – Florida Cancer Specialists & Research Institute
New FDA-Approved Drug Offers Hope for Advanced Pancreatic Cancer Patients

Daraxonrasib nearly doubled survival vs. chemotherapy in advanced pancreatic cancer. See how FCS early-phase trials helped lead to its FDA approval.

Hassan Hasanein, MD, who joined FCS through a trusted physician referral
A Trusted Referral Leads to the Right Fit at FCS

Discover how a physician referral brought oncologist Hassan Hasanein, MD, to Florida Cancer Specialists & Research Institute and why FCS was his top choice.

New targeted therapy approval represents important step forward in metastatic breast cancer care – Florida Cancer Specialists & Research Institute
New Targeted Therapy Approval Represents Important Step Forward in Metastatic Breast Cancer Care

FDA grants accelerated approval to camizestrant for ESR1-mutated HR+/HER2- metastatic breast cancer. Learn how FCS research helped lead to this new therapy.

Share This Article: